NGH.H — Nexia Health Technologies Income Statement
0.000.00%
TechnologyMicro Cap
Annual income statement for Nexia Health Technologies, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
R2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | — | — | 0.479 | 1.5 | 1.45 |
| Operating Profit | 0 | 0 | -0.479 | -1.5 | -1.45 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.97 | -0.81 | -0.453 | -1.28 | -1.45 |
| Net Income After Taxes | -0.97 | -0.81 | -0.453 | -1.28 | -1.45 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.75 | -0.923 | 1.03 | -1.28 | -1.57 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3.75 | -0.923 | 1.03 | -1.28 | -1.57 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.01 | -0.009 | -0.005 | -0.013 | -0.015 |
| Dividends per Share |